Systemic IgG4-related lymphadenopathy: A clinical and pathologic comparison to multicentric Castleman's disease

Modern Pathology

Volumn 22, Issue 4, 2009, Pages 589-599

  Sato, Yasuharu ^a   Kojima, Masaru ^b   Takata, Katsuyoshi ^a   Morito, Toshiaki ^a   Asaoku, Hideki ^c   Takeuchi, Tamotsu ^d   Mizobuchi, Kohichi ^e   Fujihara, Megumu ^c   Kuraoka, Kazuya ^f   Nakai, Tokiko ^g   Ichimura, Kouichi ^a   Tanaka, Takehiro ^a   Tamura, Maiko ^a   Nishikawa, Yuriko ^h   Yoshino, Tadashi ^a  

^a OKAYAMA UNIVERSITY   (Japan)

^b GUNMA PREFECTURAL CANCER CENTER   (Japan)

^c ATOMIC BOMB SURVIVORS HOSPITAL   (Japan)

^d KOCHI MEDICAL SCHOOL   (Japan)

^e KAGAWA ROSAI HOSPITAL   (Japan)

^f NATIONAL HOSPITAL ORGANIZATION   (Japan)

^g Kochi Health Sciences Center   (Japan)

^h OKAYAMA UNIVERSITY   (Japan)

Author keywords

C reactive protein; Immunoglobulin E; Interleukin 6; Multicentric castlemans disease; Systemic IgG4 related lymphadenopathy

Indexed keywords

AUTOANTIBODY; C REACTIVE PROTEIN; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G4; INTERLEUKIN 6; LACTATE DEHYDROGENASE; SOLUBLE INTERLEUKIN 2 RECEPTOR;

ADULT; AGED; ANGIOFOLLICULAR LYMPH NODE HYPERPLASIA; ARTICLE; BLOOD LEVEL; CELL INFILTRATION; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DIFFERENTIAL DIAGNOSIS; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LYMPHADENOPATHY; MALE; PLASMACYTOSIS; PRIORITY JOURNAL;

AGE FACTORS; AGED; AGED, 80 AND OVER; C-REACTIVE PROTEIN; DIAGNOSIS, DIFFERENTIAL; EOSINOPHILIA; FEMALE; GENE REARRANGEMENT, B-LYMPHOCYTE; GENE REARRANGEMENT, T-LYMPHOCYTE; GIANT LYMPH NODE HYPERPLASIA; HUMANS; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; IMMUNOHISTOCHEMISTRY; INTERLEUKIN-6; LYMPH NODES; LYMPHATIC DISEASES; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION;

EID: 63949083670     PISSN: 08933952     EISSN: 15300285     Source Type: Journal    
DOI: 10.1038/modpathol.2009.17     Document Type: Article

References (32)

1. Hamano H, Kawa S, Horiuchi A, et al. High serum IgG4 concentrations in patients with sclerosing pancreatitis. N Engl J Med 2001;344:732-738.
2. Hamano H, Kawa S, Ochi Y, et al. Hydronephrosis associated with retroperitoneal fibrosis and sclerosing pancreatitis. Lancet 2002;359:1403-1404.
3. Kamisawa T, Okamoto A. IgG4-related sclerosing disease. World J Gastroenterol 2008;14:3948-3955.
4. Kamisawa T, Nakajima H, Egawa N, et al. IgG4-related sclerosing disease incorporating sclerosing pancreatitis, cholangitis, sialadenitis and retroperitoneal fibrosis with lymphadenopathy. Pancreatology 2006;6: 132-137.
5. Kojima M, Miyawaki S, Takada S, et al. Lymphoplasmacytic infiltrate of regional lymph nodes in Küttner's tumor (chronic sclerosing sialadenitis): areport of 3 cases. Int J Surg Pathol 2008;16:263-268.
6. Masaki Y, Dong L, Kurose N, et al. Proposal for a new clinical entity, IgG4-positive multi-organ lymphoproliferative syndrome: analysis of 64 cases of IgG4-related disorders. Ann Rheum Dis 2008 published online 13 Aug 2008; doi: 10.1136/ard.2008.089169.
7. Sato Y, Ohshima K, Ichimura K, et al. Ocular adnexal IgG4-related disease has uniform clinicopathology. Pathol Int 2008;58:465-470.
8. Zhang L, Notohara K, Levy MJ, et al. IgG4-positive plasma cell infiltration in the diagnosis of autoimmune pancreatitis. Mod Pathol 2007;20:23-28.
9. Zen Y, Fujii T, Sato Y, et al. Pathological classification of hepatic inflammatory pseudotumor with respect to IgG4-related disease. Mod Pathol 2007;20:884-894.
10. Zen Y, Fujii T, Harada K, et al. Th2 and regulatory immune reactions are increased in immunoglobin G4- related sclerosing pancreatitis and cholangitis. Hepatology 2007;45:1538-1546.
11. Cheuk W, Yuen HKL, Chu SYY, et al. Lymphadenopathy of IgG4-related sclerosing disease. Am J Surg Pathol 2008;32:671-681.
12. Castleman B, Iverson L, Menendez VP. Localized mediastinal lymph-node hyperplasia resembling thymoma. Cancer 1956;9:822-830.
13. Flendrig JA, Schillings PHM. Benign giant lymphoma: the clinical signs and symptoms. Folia Med Neerl 1969;12:119-120.
14. Keller AR, Hochholzer L, Castleman B. Hyalinevascular and plasma-cell types of giant lymph node hyperplasia of the mediastinum and other locations. Cancer 1972;29:670-683.
15. Frizzera G, Peterson BA, Bayrd ED, et al. A systemic lymphoproliferative disorder with morphologic features of Castleman's disease: clinical findings and clinicopathologic correlations in 15 patients. J Clin Oncol 1985;3:1202-1216.
16. Nishimoto N, Kanakura Y, Aozasa K, et al. Humanized anti-interleukin-6 receptor antibody treatment of multicentric Castleman's disease. Blood 2005;106: 2627-2632.
17. Kojima M, Nakamura S, Shimizu K, et al. Clinical implication of idiopathic plasmacytic lymphadenopathy with polyclonal hypergammaglobulinemia: a report of 16 cases. Int J Surg Pathol 2004;12:25-30.
18. Kojima M, Nakamura N, Tsukamoto N, et al. Clinical implication of multicentric Castleman's disease among Japanese: a report of 28 cases. Int J Surg Pathol 2008;16:391-398.
19. Mannami T, Yoshino T, Oshima K, et al. Clinical, histopathological, and immunogenetic analysis of ocular adnexal lymphoproliferative disorders: characterization of malt lymphoma and reactive lymphoid hyperplasia. Mod Pathol 2001;14:641-649.
20. Sato Y, Nakamura N, Nakamura S, et al. Deviated VH4 immunoglobulin gene usage is found among thyroid mucosa-associated lymphoid tissue lymphomas, similar to the usage at other sites, but is not found in thyroid diffuse large B-cell lymphomas. Mod Pathol 2006;19:1578-1584.
21. Sato Y, Ichimura K, Tanaka T, et al. Duodenal follicular lymphomas share common characteristics with mucosa- associated lymphoid tissue lymphomas. J Clin Pathol 2008;61:377-381.
22. Dongen JV, Langerak AW, Brüggemann M, et al. Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: report of the BIOMED- 2 action BMH4-CT98-3936. Leukemia 2003;17: 2257-2317.
23. Koo CH, Nathwani BN, Winberg CD, et al. Atypical lymphoplasmacytic and immunoblastic proliferation in lymph nodes of patients with autoimmune disease (autoimmune-disease-associated lymphadenopathy). Medicine (Baltimore) 1984;64:274-290.
24. Kojima M, Motoori T, Hosomura Y, et al. Atypical lymphoplasmacytic and immunoblastic proliferation from rheumatoid arthritis: a case report. Pathol Res Prac 2006;202:51-54.
25. Usón J, Balsa A, Pascual-Salcedo D. Soluble interleukin 6 (IL-6) receptor and IL-6 levels in serum and synovial fluid of patients with different arthropathies. J Rheumatol 1997;24:2069-2075.
26. Nishimoto N, Terao K, Mima T, et al. Mechanisms and pathological significances in increase in serum interleukin- 6 (IL-6) and soluble IL-6 receptor after administration of anti-IL-6 receptor antibody, tocilizumab, in patients with rheumatoid arthritis and Castleman's disease. Blood 2008;112:3959-3964.
27. Castell JV, Gómez-Lechón MJ, David M, et al. Recombinant human interleukin-6 (IL-6/BSF-2/HSF) regulates the synthesis of acute phase proteins in human hepatocytes. FEBS Lett 1988;232:347-350.
28. Castell JV, Gómez-Lechón MJ, David M, et al. Acutephase response of human hepatocytes: regulation of acute-phase protein synthesis by interleukin-6. Hepatology 1990;12:1179-1186.
29. Gabay C, Kushner I. Acute-phase proteins and other systemic responses to inflammation. N Eng J Med 1999;340:448-454.
30. Yokoyama A. Interleukin-6 (IL-6) / soluble IL-6 receptor. Nippon Rinsho 2005;63:72-74.
31. Kondo E, Nakamura S, Onoue H, et al. Detection of bcl-2 protein and bcl-2 messenger RNA in normal and neoplastic lymphoid tissues by immunohistochemistry and in situ hybridization. Blood 1992;80:2044-2051.
32. Sato Y, Takata K, Ichimura K, et al. IgG4-producing marginal zone B-cell lymphoma. Int J Hematol 2008;88:428-433.